Our data suggested that the combination treatment with 5-aza-dC and IR in pancreatic cancer cells decreases the sphere-forming capacity associated with the global downregulation of Oct4-centered network of genes. The gene discussed is POU5F1; the disease is pancreatic neoplasm.